bioAffinity Technologies, Inc. (BIAF)

USD 1.04

(1.96%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 2.53 Million 4803.00 - - -
Cost of Revenue 1.74 Million 467.00 4817.00 22.24 Thousand 40.27 Thousand
Gross Profit 791.61 Thousand 4336.00 -4817.00 -22.24 Thousand -40.27 Thousand
Operating Expenses 8.76 Million 4.01 Million 2.2 Million 2.6 Million 3.05 Million
Selling, General and Administrative Expenses 6.79 Million 2.72 Million 880.77 Thousand 994.34 Thousand 1.19 Million
Research and Development Expenses 1.72 Million 1.28 Million 1.32 Million 1.61 Million 1.85 Million
Other Expenses 249.59 Thousand -1.86 Million 724.92 Thousand -4.28 Million -
Cost and Expenses 10.5 Million 4.01 Million 2.2 Million 2.6 Million 3.09 Million
Operating Income -7.97 Million -4.01 Million -2.2 Million -2.6 Million -3.09 Million
Interest Expense 37.12 Thousand 2.53 Million 1 Million 382.17 Thousand 214.83 Thousand
Income Tax Expense 20.99 Thousand 2459.00 1950.00 2750.00 3200.00
Earnings before Tax -7.91 Million -8.15 Million -6.32 Million -7.26 Million -3.3 Million
Net Income -7.93 Million -8.15 Million -6.32 Million -7.26 Million -3.3 Million
Earnings Per Share Basic -0.91 -1.81 -0.86 -0.99 -0.45
Earnings Per Share Diluted -0.91 -1.81 -0.86 -0.99 -0.45
Weighted Average Shares Outstanding 8.74 Million 4.49 Million 7.37 Million 7.37 Million 7.37 Million
Weighted Average Shares Outstanding (Diluted) 8.74 Million 4.49 Million 7.37 Million 7.37 Million 7.37 Million
Gross Margin 0.31 0.90 - - -
EBIT Margin -3.01 -1211.97 - - -
Profit Margin -3.13 -1697.71 - - -
EBITDA -7.62 Million -5.6 Million -2.2 Million -6.86 Million -3.04 Million
Earnings Before Tax Margin -3.15 -835.12 - - -

Income Statement Charts